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Introduction
Hypoxia is a hallmark of diverse human malignancies, including 
breast cancer, head and neck cancer, prostate cancer, pancreatic 
cancer, brain tumors, and malignant melanoma (Harrison and 
Blackwell, 2004). The extent of hypoxia in a tumor may represent 
an independent indicator of poor prognosis (Chia et al., 2001); 
however, the mechanisms by which hypoxia affects cancer progres-
sion remain incompletely understood. Under decreased O2 tension, 
the transcription factor, hypoxia-inducible factor 1α (HIF-1α), is 
stabilized. HIF-1α dimerizes with HIF-1β to activate a complex 
genetic program that is responsible for many hypoxia-associated 
changes in cell physiology, including expression of vascular endo-
thelial growth factor (VEGF) and induction of angiogenesis 
(Forsythe et al., 1996). Constitutive expression of HIF-1α renders 
tumor cells resistant to hypoxia and/or nutrient deprivation (Akakura 
et al., 2001). Thus, clonal selection of HIF-1α–overexpressing cells 
may increase the likelihood that tumor cells survive at implantation 
sites during metastasis (Vaupel and Harrison, 2004).
In hypoxic cancer cells, cell signaling pathways that 
support invasion and metastasis may be activated downstream 
of the hepatocyte growth factor receptor/c-Met (Pennacchietti 
et al., 2003) or the erythropoietin receptor (EpoR; Leyland-Jones, 
2003; Lester et al., 2005). Hypoxia also may induce expression 
of the urokinase-type plasminogen activator (uPA) receptor 
(uPAR; Graham et al., 1999; Rofstad et al., 2002). In breast 
cancer, uPAR expression is associated with a poor prognosis (Del 
Vecchio et al., 1993; Bianchi et al., 1994; de Vries et al., 1994). 
uPAR may promote cancer progression by multiple mechanisms 
(Ossowski and Aguirre-Ghiso, 2000; Blasi and Carmeliet, 2002). 
By binding uPA at the leading edge of the migrating cell, uPAR 
organizes a cascade of extracellular proteases that facilitate cel-
lular penetration of tissue boundaries (Andreasen et al., 1997). 
uPAR also laterally associates with integrins in the plasma mem-
brane, regulating the state of integrin activation (Wei et al., 1996, 
2001; Blasi and Carmeliet, 2002). Furthermore, uPAR functions 
in association with coreceptors, including integrins, receptor ty-
rosine kinases, and G protein–coupled receptors, to initiate sig-
nal transduction (Nguyen et al., 1999; Liu et al., 2002; Resnati 
et al., 2002; Jo et al., 2003; Kiyan et al., 2005).
uPAR-dependent cell signaling is regulated by ligands. 
Binding of uPA to uPAR activates FAK, c-Src, H-Ras, Akt, 
extracellular signal-regulated kinase (ERK)/MAPK, and myosin 
light chain kinase (Nguyen et al., 1999; Chandrasekar et al., 
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ypoxia activates genetic programs that facilitate 
cell survival; however, in cancer, it may promote 
invasion and metastasis. In this study, we show that 
breast cancer cells cultured in 1.0% O2 demonstrate 
changes consistent with epithelial–mesenchymal transition 
(EMT). Snail translocates to the nucleus, and E-cadherin is 
lost from plasma membranes. Vimentin expression, cell 
migration, Matrigel invasion, and collagen remodeling 
are increased. Hypoxia-induced EMT is accompanied by 
increased expression of the urokinase-type plasminogen 
activator receptor (uPAR) and activation of cell signaling 
factors downstream of uPAR, including Akt and Rac1. 
  Glycogen synthase kinase-3β is phosphorylated, and Snail 
expression is increased. Hypoxia-induced EMT is blocked 
by uPAR gene silencing and mimicked by uPAR over-
expression in normoxia. Antagonizing Rac1 or phosphat-
idylinositol 3-kinase also inhibits development of cellular 
properties associated with EMT in hypoxia. Breast cancer 
cells implanted on chick chorioallantoic membranes and 
treated with CoCl2, to model hypoxia, demonstrate in-
creased dissemination. We conclude that in hypoxia, uPAR 
activates diverse cell signaling pathways that cooperatively 
induce EMT and may promote cancer metastasis.
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2003; Alfano et al., 2006; Monaghan-Benson and McKeown-
Longo, 2006). uPAR also binds directly to vitronectin, and this 
interaction promotes activation of Rac1 (Kjoller and Hall, 2001; 
Ma et al., 2002). A second mechanism by which uPAR controls 
Rac1 activation is by regulating the interaction of α5β1 with 
fi  bronectin (Wei et al., 2006). These uPAR-dependent cell sig-
naling events impact cell migration and survival (Ossowski and 
Aguirre-Ghiso, 2000; Blasi and Carmeliet, 2002); however, the 
role of uPAR-initiated cell signaling in cell physiology remains 
incompletely understood.
Zhang et al. (2003) demonstrated that in kidney epithelial 
cells, α3 integrins and uPAR cooperate to induce phenotypic 
changes consistent with epithelial–mesenchymal transition (EMT). 
In cancer, EMT may be an important step leading to invasion and 
metastasis (Thompson et al., 2005). At the molecular level, EMT 
is characterized by loss of epithelial cell markers, including the 
cell adhesion protein, E-cadherin (Thiery, 2002), and acquisition 
of mesenchymal markers, such as vimentin (Grunert et al., 2003). 
A major mechanism by which E-cadherin is down-regulated 
in EMT is transcriptional repression by Snail (Nieto, 2002). 
Overexpression of Snail is sufficient to induce EMT and is 
  associated with highly invasive tumors both in mice and hu-
mans (Cano et al., 2000). In ovarian cancer cells, tumor hypoxia 
increases Snail levels and decreases E-cadherin expression 
(Imai et al., 2003). Absence of the von Hippel–Landau tumor 
suppressor in renal carcinoma cells increases the level of HIF-1α 
and is associated with decreased expression of E-cadherin 
(Krishnamachary et al., 2003). These studies suggest a relation-
ship between tumor hypoxia and EMT. Our objective was to 
further elucidate this linkage.
In this study, we demonstrate that hypoxia induces diverse 
molecular, phenotypic, and functional changes in breast cancer 
cells that are consistent with EMT. We also show that cell sig-
naling factors, which are thought to be involved in EMT, are acti-
vated in hypoxic cancer cells, including ERK/MAPK, Rac1, Akt, 
and glycogen synthase kinase-3β (GSK-3β). The EMT- associated 
phenotypic changes and changes in cell signaling are due to 
hypoxia-induced uPAR expression and activation of uPAR-
dependent cell signaling. Hypoxia-induced EMT is blocked by 
uPAR gene silencing and mimicked by uPAR overexpression 
in normoxia. Using a newly developed chick chorioallantoic 
membrane (CAM) model system, we show that hypoxic conditions 
promote cancer cell dissemination in vivo. We conclude that 
EMT may be induced in hypoxic cancer cells, by a mechanism 
that involves activation of uPAR-dependent cell signaling.
Results
MDA-MB-468 cells undergo EMT 
in hypoxia
The concentration of O2 in conventional cell culture is 21%, 
corresponding to a PO2 of 150 mm Hg, well above the PO2 of 
well-perfused tissues in vivo (40 mm Hg; Semenza, 2001). To 
better model the tumor microenvironment, particularly at the 
hypoxic core, we cultured breast cancer cells in an incubator 
adjusted to 1.0% O2. Fig. 1 A shows that after 50 h in hypoxia, 
MDA-MB-468 cells, which typically appear epithelial with 
well-developed cell junctions, acquire a spindle shape and gen-
erally lose cell contacts. Immunoblot analysis shows that MDA-
MB-468 cells express vimentin when cultured in 1.0% O2.
EMT has been defi  ned as a three-part process in which cells 
acquire a fi  broblast-like morphology, down-regulate epithelial-
specifi  c proteins such as E-cadherin while simultaneously ex-
pressing mesenchymal proteins such as vimentin, and ultimately, 
digest and migrate through ECM (Grunert et al., 2003). To further 
test whether the morphologic changes in hypoxic MDA-MB-468 
cells represent EMT, we performed immunofl  uorescence micros-
copy, examining the epithelial cell marker E-cadherin. As shown 
in Fig. 1 B, after 50 h at 1.0% O2, E-cadherin was lost from the 
cell surface in most cells. Residual E-cadherin remained local-
ized primarily in intracellular pools.
Localization of the transcription factor, Snail, was exam-
ined by costaining cells with DAPI. Under normoxic cell culture 
conditions (21% O2), immunostaining for Snail was local-
ized diffusely throughout the cytoplasm (Fig. 1 C). In contrast, 
Figure 1.  Hypoxia induces EMT in MDA-MB-468 cells. (A) Cells were 
cultured for 50 h in 21% O2 (normoxia; N) or 1.0% O2 (hypoxia; H). Cell 
images were captured by phase-contrast microscopy. Cell extracts were 
subjected to SDS-PAGE and immunoblot analysis to detect vimentin (V), 
and tubulin (T). (B–D) Cells that were incubated for 50 h in 21% O2 (N) or 
1.0% O2 (H) were immunostained to detect E-cadherin (B), Snail (C), or 
vimentin (D), in the green channel, with phalloidin (red), and with DAPI (blue). 
Bar, 50 μm.UPAR INDUCES EMT IN HYPOXIC BREAST CANCER CELLS • LESTER ET AL. 427
in 1.0% O2, Snail translocated to the nucleus. Fig. 1 D shows that 
vimentin immunostaining was substantially increased in MDA-
MB-468 cells cultured in hypoxia, confi  rming the results of our 
immunoblot analyses. In control experiments, none of the described 
antigens were detected when primary antibody was omitted.
Hypoxia promotes cell migration, Matrigel 
invasion, and ECM remodeling
EMT is thought to promote cancer cell migration and invasion 
(Grunert et al., 2003). To study the effects of hypoxia on cell 
migration, we examined cells in Transwell chambers main-
tained in 1.0 or 21% O2. The underside of each Transwell mem-
brane was coated with FBS so that vitronectin was the primary 
protein adsorbed to the surface in a haptotactic gradient (Hayman 
et al., 1983). 10% FBS also was added to the bottom chamber as 
a chemoattractant. MDA-MB-468 cells were added to each 
Transwell in a single-cell suspension. As shown in Fig. 2 A, cell 
migration was increased 2.2 ± 0.1-fold (P < 0.001; n = 21) in 
1.0% O2. Similarly, invasion of MDA-MB-468 cells through 
reconstituted 3D Matrigel matrices was increased 2.3 ± 0.2-fold 
(P < 0.001; n = 10) in 1.0% O2.
To confi  rm these results using a second experimental 
protocol, we treated MDA-MB-468 cells with CoCl2, which stabi-
lizes HIF-1α and mimics many of the cellular changes observed 
in hypoxia (Schuster et al., 1989; Wang and Semenza, 1993). 
100 μM CoCl2 increased MDA-MB-468 cell migration 1.8 ± 
0.1-fold (P < 0.005; n = 3) compared with vehicle-treated con-
trol cultures (Fig. 2 B). These results support a model in which 
hypoxia-induced EMT, in MDA-MB-468 cells, is associated 
with more aggressive cell behavior. To further test this model, 
we compared the ability of MDA-MB-468 cells to remodel 
fl  uorescein-labeled type I collagen in 1.0 and 21% O2. The colla-
gen was adsorbed to microscope coverslips and labeled with 
fl  uorescein before adding cells. As shown in Fig. 2 C, remodeling 
of the fl  uorescent collagen was substantially increased when the 
coverslips were maintained in 1.0% O2.
Signaling pathways downstream of uPAR 
are activated in hypoxia
We previously demonstrated that activation of EpoR-dependent 
cell signaling promotes migration of MCF-7 breast cancer cells 
in hypoxia (Lester et al., 2005). Therefore, we tested whether 
Epo or EpoR are up-regulated in hypoxic MDA-MB-468 cells; 
however, this was not the case (unpublished data). Instead, 
MDA-MB-468 cells demonstrated substantially increased uPAR 
expression, as determined by immunoblot analysis (Fig. 3 A). 
uPAR expression also was increased when MDA-MB-468 cells 
were treated with CoCl2 (unpublished data). These results, taken 
in the context of our previous study (Lester et al., 2005), suggest 
that receptor activation to promote cell migration and invasion 
in hypoxia may occur in a cell-specifi  c manner.
We hypothesized that activation of uPAR-dependent cell 
signaling may be responsible for the molecular and morpholog-
ical changes observed in MDA-MB-468 cells under hypoxic 
Figure 2.  Hypoxia promotes cell migration, invasion, and collagen 
remodeling. (A) MDA-MB-468 cells were added to Transwell chambers, in 
which the membranes were precoated with FBS (cell migration; n = 21) or 
in which reconstituted Matrigel was present (cell invasion; n = 10). Studies 
were performed for 24 h in 21% O2 (gray bar) or 1.0% O2 (black bar). 
Migration and invasion are expressed relative to the levels observed with 
normoxic controls (mean ± SEM). (B) MDA-MB-468 cells were treated with 
CoCl2 or with vehicle. Cells were allowed to migrate for 24 h. Cell migra-
tion is expressed relative to that observed with vehicle (mean ± SEM; n = 3). 
*, P < 0.05; **, P < 0.005. (C) Cells were cultured for 18 h on ﬂ  uorescein-
labeled type I collagen in 21% (normoxia) or 1.0% O2 (hypoxia). Type I 
collagen remodeling was assessed. Cell nuclei are stained with DAPI. 
Bar, 50 μm.
Figure 3.  Hypoxia increases uPAR levels and activates cell signaling 
factors known to be downstream of uPAR. (A) MDA-MB-468 cells were cul-
tured for 24 h in 21% O2 (N) or 1.0% O2 (H). Cell extracts were subjected 
to SDS-PAGE and immunoblot analysis to detect human uPAR using antibody 
3932 and tubulin. (B) MDA-MB-468 cells were cultured for 15 h in 21% O2 (N) 
or 1.0% O2 (H), treated with 100 μM CoCl2 or with vehicle (control; C). 
Cell extracts were afﬁ   nity precipitated with PAK-1 PBD and subjected to 
  immunoblot analysis to detect GTP-bound Rac1. The original cell extracts 
were studied by immunoblot analysis to determine total Rac1. Cell extracts 
were also probed for phosphorylated ERK/MAPK and HIF-1α. (C) The 
  results of three separate experiments were averaged to determine the per-
centage of increase in activated Rac1 in hypoxia (mean ± SEM; n = 3).JCB • VOLUME 178 • NUMBER 3 • 2007  428
conditions. To test this hypothesis, fi  rst we examined the basal 
level of activation of ERK/MAPK and Rac1 in cells that were 
transferred to 1.0% O2. Fig. 3 B shows that both signaling pro-
teins were activated in 1.0% O2 or when the cells were treated 
with 100 μM CoCl2. Because CoCl2 was less effective in acti-
vating ERK/MAPK and Rac1, compared with hypoxia, we also 
assessed the relative abundance of HIF-1α under both sets of 
conditions and determined that HIF-1α levels were increased 
more substantially in hypoxia. The extent of Rac1 activation in 
1.0% O2 was statistically signifi  cant (1.7 ± 0.2-fold; P < 0.05; 
Fig. 3 C). Higher levels of Rac1 activation were not anticipated, 
as we analyzed whole cell extracts and Rac1 activation is known 
to occur locally, at the subcellular level, in the migrating cell 
(Cho and Klemke, 2002).
uPAR is required for hypoxia-induced EMT
To test whether uPAR is responsible for the increase in cell mi-
gration observed in hypoxia, we treated MDA-MB-468 cells 
with antibodies that block uPA binding to uPAR and inhibit 
uPAR-initiated cell signaling (Jo et al., 2007). Fig. 4 A shows 
that the antibodies inhibited the increase in cell migration ob-
served in hypoxia by 90 ± 7% (P < 0.005; n = 6) without 
affecting cell migration in 21% O2. Next, we applied a gene 
silencing approach. Stable subclones of MDA-MB-468 cells, in 
which uPAR is silenced, were generated using the pSUPER 
vector system to express short hairpin (sh) RNA. Two cell lines, 
sh-uPAR6 and sh-uPAR12 cells, demonstrated 86 ± 2 and 70 ± 
9% uPAR knockdown, respectively, as determined by quantita-
tive PCR (qPCR), compared with parental cells that were trans-
fected with empty vector (Fig. 4 B). In 1.0% O2, the degree 
of knockdown was 93 ± 1 and 78 ± 2% in sh-uPAR6 and 
sh-uPAR12 cells, respectively.
Under normoxic conditions, migration of sh-uPAR6 and 
sh-uPAR12 cells was not signifi  cantly affected compared with 
pSUPER cells; however, when the sh-uPAR6 and sh-uPAR12 
cells were transferred to 1.0% O2, the hypoxia-induced increase 
in cell migration was inhibited by >70% (Fig. 4 C). In Matrigel 
invasion experiments performed under normoxic conditions, 
uPAR gene silencing had a modest effect. sh-uPAR12 cells dem-
onstrated a 47 ± 10% decrease in Matrigel invasion, compared 
with uPAR-expressing cells (P < 0.05; n = 6). The decrease in 
invasion was less pronounced with sh-uPAR6 cells. However, 
once again, when the experiment was performed in 1.0% O2, 
the effects of uPAR gene silencing were more profound. The 
hypoxia-induced increase in Matrigel invasion was inhibited by 
>80% in the sh-uPAR6 and sh-uPAR12 cells (Fig. 4 C).
Next, we tested the effects of uPAR gene silencing on 
Rac1 activation in hypoxia. MDA-MB-468 cells that were 
transfected with empty vector demonstrated increased Rac1 
activation when cultured in 1.0% O2, as was observed with the 
parental cells; however, Rac1 was not activated by hypoxia in 
the sh-uPAR6 and sh-uPAR12 cells (Fig. 4 D). These results 
support a model in which uPAR plays an essential role in the 
regulation of Rac1 activation in hypoxia.
To further test the role of uPAR in hypoxia-induced MDA-
MB-468 cell EMT, we examined the effects of uPAR gene si-
lencing on cell morphology and E-cadherin immunostaining. 
When cultured in 1.0% O2, the control cells, which were trans-
fected with empty vector, adopted a fi  broblast-like morphology 
and demonstrated loss of cell surface E-cadherin, duplicating 
the changes observed with the parental cells (Fig. 5 A). In con-
trast, sh-uPAR6 and sh-uPAR12 cells, which were cultured in 
1.0% O2, demonstrated unchanged epithelial cell–like morphol-
ogy with abundant cell contacts. E-cadherin immunostaining was 
unchanged (Fig. 5 A).
We also performed studies to compare collagen remodeling 
by the uPAR-expressing and gene-silenced cells. The three 
cell lines were plated on coverslips coated with fl  uorescein-
labeled type I collagen. Under normoxic conditions, considerable 
remodeling of the fl  uorescent collagen was not observed with 
any of the cells (Fig. 5 B). In 1.0% O2, the uPAR-expressing 
pSUPER cells demonstrated substantial collagen remodeling, 
as was observed with parental cells. In contrast, the sh-uPAR6 
and sh-uPAR-12 cells failed to demonstrate collagen remodeling. 
Collectively, these results demonstrate that uPAR is required for 
hypoxia-induced EMT in MDA-MB-468 cells.
Figure 4.  uPAR is necessary for hypoxia-promoted cell migration, inva-
sion, and Rac1 activation. (A) MDA-MB-468 cells were pretreated with 
25 μg/ml uPA-speciﬁ  c antibody 3471 and 25 μg/ml uPAR-speciﬁ  c anti-
body 399R or with 50 μg/ml control IgG. Cells were allowed to migrate 
in Transwell chambers for 24 h in 21% O2 (gray bars) or 1.0% O2 (black 
bars). Cell migration is expressed as a percentage of that observed with 
control IgG in normoxia (mean ± SEM; n = 6). (B) MDA-MB-468 cells ex-
pressing empty vector (pSUPER), sh-uPAR6 cells, and sh-uPAR12 cells were 
cultured for 24 h in 21% O2 (gray bars) or 1.0% O2 (black bars). uPAR 
mRNA was determined by qPCR. Results are normalized against HPRT-1 
and compared with the level observed in the pSUPER cells in normoxia 
(mean ± SEM; n = 3). (C) pSUPER, sh-uPAR6, and sh-uPAR12 cells were 
allowed to migrate in Transwell chamber (cell migration) or to invade 
Matrigel (cell invasion) for 24 h in 21% O2 (gray bars) or 1.0% O2 (black 
bars). Results are expressed as a percentage of that observed with pSUPER 
cells in normoxia (mean ± SEM; n = 7 and n = 6, respectively). (D) pSUPER, 
sh-uPAR6, and sh-uPAR12 cells were cultured for 15 h in 21% O2 (N) or 
in 1.0% O2 (H). Cell extracts were afﬁ  nity precipitated with PAK-1 PBD 
and subjected to immunoblot analysis to determine GTP-bound Rac1. The 
original extracts were subjected to immunoblot analysis for tubulin, as a 
loading control.UPAR INDUCES EMT IN HYPOXIC BREAST CANCER CELLS • LESTER ET AL. 429
Rac1 is required for MDA-MB-468 
cell migration, invasion, and collagen 
remodeling in hypoxia
Although activation of ERK/MAPK and Rac1 is associated 
with increased cell migration and with the other properties ob-
served in hypoxic MDA-MB-468 cells, the effects of these cell 
signaling pathways on cell physiology are cell type specifi  c. 
Factors that may determine whether activation of ERK/MAPK 
and/or Rac1 regulate cell migration include but are not limited 
to the integrin expression pattern of the cell and the composition 
of the substratum (Anand-Apte et al., 1997; Nguyen et al., 
1999). In MCF-7 cells, activation of endogenous EpoR cell 
signaling in hypoxia promotes cell migration by a pathway that 
requires ERK/MAPK. Dominant-negative (DN) MEK1 and 
PD098059 block the response (Lester et al., 2005). However, as 
shown in Fig. 6 A, in MDA-MB-468 cells, DN-MEK1 failed to 
inhibit the increase in cell migration induced by hypoxia. Simi-
larly, PD098059 failed to inhibit the increase in cell migration 
caused by CoCl2 (Fig. 6 B). We also studied the effects of 
DN-MEK1 expression on Matrigel invasion by MDA-MB-468 
cells. Again, no inhibition was observed (Fig. 6 A).
Next, we tested the effects of DN-Rac1 on hypoxia-induced 
cell migration and invasion. As shown in Fig. 6 C, under nor-
moxic cell culture conditions, DN-Rac1 did not affect cell migra-
tion and modestly decreased invasion (45 ± 16%; P < 0.05). In 
contrast, DN-Rac1 almost entirely neutralized the effects of hyp-
oxia on cell migration and Matrigel invasion. We confi  rmed these 
results in separate experiments in which we treated cells with 
100 μM CoCl2 (instead of hypoxia). DN-Rac1 inhibited the CoCl2-
induced increase in cell migration by 87 ± 11% (P < 0.05; n = 3; 
unpublished data). We also showed that cells that were trans-
fected to express DN-Rac1 and GFP demonstrate decreased col-
lagen remodeling compared with cells that were transfected to 
express GFP alone (Fig. 6 D). Thus, DN-Rac1 inhibited changes 
Figure 5.  uPAR is necessary for hypoxia-induced EMT and collagen 
remodeling. (A) pSUPER, sh-uPAR6, and sh-uPAR12 cells were cultured for 
50 h in 21% O2 (N) or 1.0% O2 (H). The preparations were immuno-
stained for E-cadherin (green channel), phalloidin (red channel), and DAPI. 
(B) pSUPER, sh-uPAR6, and sh-uPAR12 cells were cultured for 18 h on cover-
slips precoated with ﬂ  uorescein-labeled type I collagen in 21% O2 (N) or 
1.0% O2 (H). Cell nuclei are stained with DAPI. Bars, 50 μm.
Figure 6.  Rac1 is necessary for hypoxia-induced cell migration, invasion, 
and collagen remodeling. (A) MDA-MB-468 cells were transfected to ex-
press DN-MEK1 and GFP or GFP alone. Cells were allowed to migrate for 
24 h in Transwell chambers (cell migration) or in chambers with reconsti-
tuted Matrigel (cell invasion). Experiments were performed in 21% O2 
(gray bars) or 1.0% O2 (black bars). Migration and invasion are com-
pared with the levels observed with normoxic control cells that expressed 
GFP (mean ± SEM; n = 3). (B) MDA-MB-468 cells were treated with 100 
μM CoCl2 (black bars) or with vehicle (gray bars). The same cells also 
were treated with 50 μM PD098059 or vehicle (control), as indicated. 
Transwell migration proceeded for 24 h. Cell migration is expressed rela-
tive to that observed with cells treated with vehicle (mean ± SEM; n = 3). 
(C) MDA-MB-468 cells were transfected to express DN-Rac1 and GFP or 
GFP alone. Cells were allowed to migrate for 24 h in Transwell chambers 
(cell migration) or in chambers with reconstituted Matrigel (cell invasion) in 
21% O2 (gray bars) or 1.0% O2 (black bars). Results are expressed rela-
tive to that observed in normoxic control cells that expressed only GFP 
(mean ± SEM; n = 6). (D) Cells were transfected to express DN-Rac1 and 
GFP or GFP alone and cultured for 18 h on collagen labeled with Alexa 
Fluor 594 in 21% O2 (normoxia) or 1.0% O2 (hypoxia). Nuclei are stained 
with DAPI. Bar, 50 μm.JCB • VOLUME 178 • NUMBER 3 • 2007  430
in three separate functional properties that were associated with 
EMT in MDA-MB-468 cells under hypoxia.
Phosphatidylinositol 3-kinase (PI3K)–Akt 
signaling is necessary for uPAR-induced 
EMT in MDA-MB 468 cells
Diverse cell signaling factors have been implicated in EMT, 
including Rac1, c-Src, Ras, FAK, and PI3K–Akt (Zhang et al., 
2003; Larue and Bellacosa, 2005; Matos and Jordan, 2006). 
These factors may operate in concert and possibly in a cell-
specifi  c manner. Because recent studies indicate that the PI3K–Akt 
pathway is activated by uPA binding to uPAR (Chandrasekar 
et al., 2003; Alfano et al., 2006), we explored the role of Akt in 
hypoxia-induced EMT. As shown in Fig. 7 A, when MDA-MB-
468 cells were cultured in 1.0% O2, the level of phosphorylated 
Akt (p-Akt) was substantially increased.
In EMT, an important function of Akt is regulation of GSK-
3β activity. Akt-induced GSK-3β phosphorylation results in 
GSK-3β inactivation. Otherwise, GSK-3β stabilizes epithelial cell 
morphology by targeting Snail. GSK-3β regulates Snail activity by 
inhibiting Snail expression, promoting Snail degradation, and de-
creasing nuclear localization (Zhou et al., 2004; Bachelder et al., 
2005). Fig. 7 A shows that in hypoxia, the level of phosphorylated 
GSK-3β in MDA-MB-468 cells was increased. Snail expression 
also was increased at both the protein and mRNA levels. Snail 
mRNA was increased 2.9 ± 0.6-fold (P < 0.05; n = 4) after expo-
sure to 1.0% O2 for 15 h, as determined by qPCR (Fig. 7 B).
To determine whether uPAR is necessary for Akt activa-
tion in hypoxia, we treated MDA-MB-468 cells with synthetic 
peptide, α325, which disrupts uPAR–integrin interactions and 
blocks uPAR-initiated cell signaling (Wei et al., 2001; Jo et al., 
2007). Fig. 7 C shows that α325 blocked hypoxia-induced Akt 
phosphorylation. The scrambled version of α325 (scα325) had 
no effect. Fig. 7 D shows that 10 μM of the PI3K inhibitor, 
LY294002, blocked the increase in Snail protein level seen in 
hypoxia. LY294002 also preserved epithelial cell morphology 
and cell contacts in MDA-MB-468 cells that were exposed to 
1.0% O2 for 50 h, as determined by phase-contrast imaging 
(Fig. 7 E). Equivalent results were obtained with 5 μM Akt 
inhibitor (unpublished data). Furthermore, LY294002 preserved 
cell surface E-cadherin in MDA-MB-468 cells in hypoxia 
(Fig. 7 F). These results suggest that uPAR-dependent Akt acti-
vation is essential for hypoxia-induced EMT. To further test this 
conclusion, we examined Snail mRNA levels in cells that were 
treated with LY294002 or vehicle for 50 h. LY294002 decreased 
Snail mRNA by 45 ± 8% in 21% O2 and by 75 ± 2% in 1.0% O2 
(P < 0.05; n = 3), completely neutralizing the effects of hypoxia 
on Snail mRNA expression (Fig. 7 G).
uPAR overexpression induces EMT 
in MDA-MB-468 cells in normoxia
Hypoxia activates complex gene expression programs down-
stream of HIF-1α and other transcription factors (Harris, 2002). 
Although the data presented thus far indicate that uPAR is 
Figure 7.  uPAR-dependent activation of the 
PI3K–Akt pathway is necessary to induce EMT 
in hypoxia. (A and B) MDA-MB-468 cells were 
cultured for 15 h in 21% O2 (N) or 1.0% O2 (H). 
(A) Cell extracts were subjected to immuno-
blot  analysis to detect phosphorylated Akt 
(p-Akt), phosphorylated GSK-3β (p-GSK-3β), 
Snail, and tubulin. (B) Snail mRNA was de-
termined by qPCR (mean ± SEM; n = 4). 
(C) MDA-MB-468 cells were treated with 50 μM 
synthetic peptide (α325) or 50 μM scrambled 
peptide (scα325) for 15 h in 21% O2 (N) or 
1.0% O2 (H). Cell extracts were subjected to 
immunoblot analysis to detect phosphorylated 
Akt and tubulin. (D) MDA-MB-468 cells were 
treated with10 μM of the PI3K inhibitor 
LY294002 or with vehicle for 15 h in 21% O2 
(normoxia) or 1.0% O2 (hypoxia). Cell extracts 
were subjected to immunoblot analysis to de-
tect Snail and tubulin (representative of three 
studies). All lanes are from the same immuno-
blot (same exposure). (E–G) MDA-MB-468 
cells were treated with 10 μM LY294002 or 
vehicle (control) and cultured for 50 h in 21% 
O2 (normoxia; N) or 1.0% O2 (hypoxia; H). 
(E) Cell images were captured using phase-
contrast microscopy. (F) Cells were immuno-
stained to detect E-cadherin (green). The same 
cells were stained with phalloidin (red) and 
DAPI. (G) Snail mRNA was determined by 
qPCR. Results are compared with the level ob-
served in control cells in normoxia (mean ± 
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necessary for EMT in hypoxic MDA-MB-468 cells, we wished 
to test whether uPAR alone induces EMT in MDA-MB-468 
cells. To accomplish this goal, we overexpressed uPAR in 
MDA-MB-468 cells and studied these cells under normoxic cell 
culture conditions. Initially, we performed transient transfection 
experiments, introducing a full-length human uPAR expression 
construct in pcDNA together with pMAX-GFP, which encodes 
GFP. Control cells were transfected with pMAX-GFP alone. 
Migration and Matrigel invasion were studied. Fig. 8 A shows 
that transient transfection with uPAR increased cell migration 
by 2.1 ± 0.3-fold (P < 0.05; n = 9) and Matrigel invasion by 
2.0 ± 0.2-fold (P < 0.005; n = 8).
To examine the effects of uPAR on morphologic and molec-
ular parameters of EMT, stable cell lines that overexpress uPAR 
were cloned. Fig. 8 B shows two cell lines (C14 and C18) in 
which uPAR expression was substantially increased. Control cells 
that were transfected with empty vector (pcDNA) demonstrated 
equivalent levels of uPAR compared with parental cells; the 
uPAR is not apparent in the fi  gure because of exposure time. 
uPAR overexpression in the C14 and C18 cells induced ex-
pression of vimentin and decreased E-cadherin expression, as 
determined by immunoblot analysis (Fig. 8 B). Phase-contrast 
imaging of the C14 and C18 cells in 21% O2 (normoxia) re-
vealed loss of cell contacts (Fig. 8 C). Furthermore, in immuno-
fl  uorescence microscopy studies, E-cadherin was substantially 
lost from the cell membranes of C14 and C18 cells and local-
ized more diffusely in the cytoplasm (Fig. 8 D). These results 
indicate that uPAR overexpression independently induces EMT 
in MDA-MB-468 cells, without exposure to hypoxia.
Hypoxia promotes MDA-MB-468 cell 
dissemination in vivo
To determine whether hypoxia may promote cancer cell dis-
semination in vivo, we modifi  ed the chicken egg CAM model of 
Kim et al. (1998). MDA-MB-468 cells were stably transfected 
to express GFP. To promote tumor growth on the CAMs, the 
cells were suspended in Matrigel and applied to a 1-cm
2 sterile 
cotton gauze that was placed on the CAM. Fig. 9 A shows 
a stereomicroscope image of a tumor that developed after 11 d. 
The GFP-expressing cells are shown in Fig. 9 B.
To model hypoxia, 25 μl of 100 μM CoCl2 vehicle was ap-
plied to the tumor-bearing gauze daily. qPCR studies, performed 
4 d after initiating treatment, demonstrated a 3.0 ± 0.7-fold 
increase in VEGF mRNA expression (P < 0.05; n = 3) by the 
CoCl2-treated cells compared with controls  (Fig. 9 C). The prim-
ers and probes used for these studies were specifi  c for human 
VEGF. Human uPAR mRNA also was increased 2.6 ± 0.4-fold 
in the MDA-MB-468 cells that were treated with CoCl2 (P < 
0.01; n = 3). These results suggest that CoCl2 treatment induces 
changes in MDA-MB-468 cells on CAMs that are equivalent to 
those observed in cell culture.
To determine whether CoCl2 treatment modifi  es the pro-
pensity of MDA-MB-468 cells to disseminate in vivo, the eggs 
were killed 11 d after inoculation. The heart–lung block was 
isolated from each chick embryo, and the number of fl  uorescent 
cells or cell clusters was determined by fl  uorescence microscopy. 
In chick embryos that were treated with vehicle, the mean 
number of fl  uorescent cells/cell clusters detected was 9 ± 2 
(n = 13; Fig. 9 D). In chick embryos that were treated with 
CoCl2, the mean was 25 ± 5 (n = 9). Thus, CoCl2 treatment 
induced a 2.7 ± 0.6-fold increase in cancer cell dissemination 
to the heart–lung block (P < 0.01). The complete process of 
cancer metastasis includes implantation, survival, and growth at 
the secondary site. Our CAM assays were not designed to assess 
these latter stages of the metastasis cascade because of the rela-
tively short length of the experiments. Nevertheless, our results 
still suggest that conditions that model hypoxia in vivo may in-
crease the propensity for cancer cell metastasis.
uPAR expression is increased and EMT 
induced in multiple cell lines under hypoxia
Increased uPAR expression was previously reported in MDA-
MB-231 breast cancer cells under hypoxia (Graham et al., 
1999). To test whether uPAR expression is increased in hypoxia 
Figure 8.  uPAR overexpression is sufﬁ  cient to induce EMT under normoxia. 
(A) MDA-MB-468 cells were cotransfected to transiently express GFP and 
uPAR (uPAR) or empty vector (pcDNA). Cells were allowed to migrate in 
Transwell chambers (cell migration; n = 9) or invade Matrigel (cell invasion; 
n = 8) for 24 h. Results are expressed as a percentage of that observed with 
normoxic GFP-expressing control cells (mean ± SEM). (B) Extracts from cells 
transfected with empty vector, uPAR-overexpressing C14 cells, and uPAR-
overexpressing C18 cells were subjected to immunoblot analysis to detect 
uPAR and total ERK/MAPK, as a loading control. Equivalent cell extracts 
were probed to detect E-cadherin, vimentin, and total ERK/MAPK. All lanes 
are from the same immunoblot (same exposure). (C) pcDNA, C14, and 
C18 cells were cultured in 21% O2. Representative images were captured 
by phase-contrast microscopy. (D) pcDNA, C14, and C18 cells were immuno-
stained to detect E-cadherin (green channel). The same cells also were 
stained with phalloidin (red channel) and DAPI. Bars, 50 μm.JCB • VOLUME 178 • NUMBER 3 • 2007  432
in diverse cancer cells, we screened a series of cell lines by 
qPCR. Signifi  cantly increased uPAR mRNA was observed when 
MDA-MB-468 cells were cultured in 1.0% O2 (Fig. 10 A) as 
anticipated (P < 0.01; n = 5). MDA-MB-231 cells also demon-
strated signifi  cantly increased uPAR mRNA in hypoxia (P < 
0.05; n = 4), consistent with the study of Graham et al. (1999). 
Other cell lines that demonstrated signifi  cantly increased uPAR 
mRNA when exposed to hypoxia included the following: A431 
epidermoid carcinoma cells (P < 0.05; n = 3), ZR-75-1 breast 
cancer cells (P < 0.005; n = 4), and SCC15 squamous cell car-
cinoma cells (P < 0.05; n = 3). Increased uPAR mRNA was 
not observed under hypoxic conditions in MDA-MB-435 cells 
or SK-BR3 cells. MCF-7 cells express extremely low levels of 
uPAR in 1.0 or 21% O2, possibly explaining the predominant 
role of the EpoR in hypoxia in this cell line (Lester et al., 2005). 
The comparisons shown in Fig. 10 A are accurate to the extent 
that expression of the housekeeping gene, hypoxanthine phos-
phoribosyltransferase 1 (HPRT-1), is conserved in the various 
cells under the conditions of the experiment.
Next, we sought to determine whether EMT is induced in 
the cells in which uPAR expression is increased in hypoxia. As 
MDA-MB-231 cells already exhibit a mesenchymal phenotype, 
we excluded this cell line from our analysis. A431 cells did not 
demonstrate EMT-associated changes in hypoxia. In contrast, 
both the ZR-75-1 and SCC15 cells demonstrated phenotypic and 
molecular changes consistent with EMT. Fig. 10 B shows that 
the ZR-75-1 cells lost cell contacts and grew more independently 
in 1.0% O2. The vimentin level was increased in hypoxia, as de-
termined by immunoblot analysis. The morphology of SCC15 
cells in normoxic cell culture was slightly different than that 
demonstrated by the breast cancer cells, probably because this 
cancer cell line was derived from squamous cell epithelium, as 
opposed to columnar epithelium. Again, in 1.0% O2, cell con-
tacts were lost and the cells grew more independently. Vimentin 
expression was increased at the protein level, as determined by 
immunoblot analysis. Thus, hypoxia increased uPAR expression, 
and this was correlated with EMT-like changes in many, but not 
all, of the cancer cells studied.
Discussion
Solid tumor growth is limited by the extent of vascularization. 
Hypoxia generally develops within 100–200 μm from blood 
vessels (O’Reilly et al., 1996). Without compensatory adapta-
tions, severe hypoxia causes tumor cell death. This is evident in 
many human cancers and in xenografts, which typically demon-
strate large areas of necrosis. Cellular adaptations observed in 
local hypoxia include changes in cell signaling and gene ex-
pression, which promote not only cell survival, but also cell 
  migration, invasion, metastasis, and resistance to chemotherapy 
(Zhou et al., 2006). Hypoxia-induced changes in cell physiol-
ogy occur downstream of HIF-1α (Semenza, 2004) and other 
global transcription factors, such as cAMP regulatory element 
binding protein (Arany et al., 1996), and are thus polygenic. 
Figure 9. CoCl2 treatment promotes MDA-MB-468 cancer cell dissemina-
tion from CAMs. GFP-expressing MDA-MB-468 cells were inoculated onto 
CAMs at 9 d. Tumors were allowed to develop for 11 d. The cells on the 
CAMs were treated daily with 25 μl of 100 μM CoCl2 (black bars) or 
vehicle (gray bars). (A) Primary tumors were photographed on a stereomicro-
scope. (B) GFP-expressing cells were imaged by ﬂ  uorescence microscopy. 
(C) Tumors from some eggs were harvested 4 d after inoculation. RNA was 
isolated and analyzed by qPCR to determine levels of VEGF and uPAR 
mRNA. mRNA levels were standardized against the levels present in vehicle-
treated tumors (mean ± SEM; n = 3). (D) Chick embryos were harvested 
11 d after inoculation of tumor cells on the CAMs. The number of GFP-
expressing cells/cell clusters in the heart–lung block was determined by 
ﬂ  uorescent microscopy (mean ± SEM; n = 9).
Figure 10.  uPAR expression and EMT in hypoxic cancer cell lines. 
(A) MDA-MB-468 (468), MCF-7, MDA-MB-231 (231), MDA-MB-435 (435), 
SK-BR3, A431, ZR-75-1 (ZR75), and SCC15 (SCC) cells were cultured in 
21% O2 (gray bars) or 1.0% O2 (black bars). uPAR mRNA was determined 
by qPCR and standardized against the level present in MDA-MB-468 cells 
under normoxia (mean ± SEM; n ≥ 3). *, P < 0.05. (B) ZR-75-1 and 
SCC15 cells were cultured in 21% O2 (normoxia) or 1.0% O2 (hypoxia). 
Images were captured using phase-contrast microscopy. Cell extracts were 
subjected to immunoblot analysis to detect vimentin (V) and tubulin (T). 
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Understanding the overall effects of hypoxia on cancer cell 
physiology is an important goal; however, it is also important to 
identify individual gene products that may be targeted to counter-
act the adverse effects of hypoxia in cancer.
In this study, we show that hypoxia induces EMT in breast 
cancer cells, building on previous studies in which aspects of 
EMT were reported in hypoxic ovarian carcinoma cells and in 
renal cell carcinoma (Imai et al., 2003; Krishnamachary et al., 
2006). For the fi  rst time, we report that uPAR is essential for 
hypoxia-induced EMT in breast cancer cells. uPAR expression 
is increased in MDA-MB-468 cells that are cultured in 1.0% O2, 
and silencing of uPAR prevents hypoxia-induced EMT. Further-
more, when uPAR is overexpressed in MDA-MB-468 cells, 
these cells undergo EMT in normoxic cell culture. Zhang et al. 
(2003) demonstrated EMT in kidney epithelial cells that were 
transfected to express α3 integrin and uPAR. Our studies extend 
their work by showing the relationship of uPAR to EMT in can-
cer cells, by demonstrating the importance of uPAR-dependent 
cell signaling, and by linking uPAR to EMT in hypoxia.
EMT refers to a series of phenotypic and molecular 
changes that occur in various steps of normal development and 
in cancer cells. When EMT occurs in cancer, the prognosis may 
be adversely affected (Larue and Bellacosa, 2005). Several cell 
signaling factors have been implicated. Akt may play a central 
role (Grille et al., 2003; Cheng et al., 2005; Larue and Bella-
cosa, 2005). A constitutively active mutant of Akt induces EMT 
in carcinoma cell lines (Grille et al., 2003). Rac1 also has been 
implicated in EMT. Initially, an alternatively spliced variant of 
Rac1, called Rac1b, which exists primarily in the GTP-loaded 
form, was shown to promote EMT in cancer cells (Singh et al., 
2004; Radisky et al., 2005); however, there is also evidence that 
pathways that result in activation of the predominant form of 
Rac1 may have the same effect (Matos and Jordan, 2006). Other 
oncogenes, including c-Src and Ras, have been implicated in 
EMT (Larue and Bellacosa, 2005). Rac1, Akt, c-Src, and Ras 
are all activated downstream of uPAR (Blasi and Carmeliet, 
2002). Thus, we favor a model in which hypoxia-induced uPAR 
expression activates cell signaling down diverse pathways that 
are complementary in inducing the full spectrum of cellular 
changes observed in EMT.
To test our model, we studied two separate uPAR-depen-
dent cell signaling pathways in MDA-MB-468 cells. We showed 
that Akt is activated in hypoxia and this response is blocked by 
peptide α325, implicating uPAR (Wei et al., 2001; Jo et al., 
2007). The PI3K inhibitor, LY294002, and Akt inhibitor pre-
vented loss of cell contacts in hypoxia. LY294002 also inhibited 
hypoxia-induced Snail expression and preserved cell surface 
E-cadherin. These results are best explained by the activity of 
Akt as a negative regulator of GSK-3β, which controls Snail by 
suppressing NF-κB–dependent Snail expression, by targeting 
Snail for degradation, and by inhibiting Snail nuclear localiza-
tion (Zhou et al., 2004; Bachelder et al., 2005). These GSK-3β 
activities limit the ability of Snail to function as an E-cadherin 
transcriptional repressor (Batlle et al., 2000). The linkage of 
uPAR to Akt activation in hypoxia provides one mechanism by 
which uPAR may regulate Snail and thus promote EMT. In the 
same cell culture model system, antagonizing Rac1 blocked the 
increase in cell migration, Matrigel invasion, and collagen re-
modeling, which were observed in hypoxia. In our hands, it was 
not possible to generate stable cultures of DN-Rac1–expressing 
MDA-MB-468 cells because the cells were not sustainable. 
Therefore, it was not possible to accurately assess morphologic 
indices of EMT in cells transfected with DN-Rac1. Neverthe-
less, our evidence indicates that targeting either Rac1 or the 
PI3K–Akt pathway blocks cellular properties associated with 
uPAR-induced EMT in hypoxic breast cancer cells.
Rac1 has emerged as an important cell signaling factor 
downstream of uPAR in diverse experimental systems (Kjoller 
and Hall, 2001; Ma et al., 2002; Vial et al., 2003; Wei et al., 
2006). uPAR-dependent Rac1 activation does not require uPA, 
although ERK/MAPK activation by uPA increases uPAR ex-
pression (Ma et al., 2001), and this may indirectly lead to an 
increase in Rac1 activation (Vial et al., 2003). Vitronectin is a 
provisional ECM protein, which accumulates at sites of infl  am-
mation (Schvartz et al., 1999), and thus should be available to 
activate the uPAR–Rac1 pathway in many malignancies. A re-
cently described pathway in which uPAR supports integrin α5β1 
in activating Rac1 (Wei et al., 2006) expands the continuum of 
contexts in which uPAR may control Rac1 in vivo.
Because hypoxia and CoCl2 promoted breast cancer cell 
migration and Matrigel invasion in vitro, we wished to study 
whether hypoxia promotes metastasis in vivo. To accomplish 
this goal, we established a new model system in which GFP-
expressing MDA-MB-468 cells were inoculated onto chicken 
egg CAMs and treated daily with 100 μM CoCl2. After 11 d, we 
assessed the number of fl  uorescent cells/cell clusters in the 
heart–lung block. We interpreted the presence of cancer cells in 
the heart–lung block as evidence that the cancer cells had pene-
trated into the vascular compartment of the chick embryo. In 
control in vitro experiments, we examined the effects of CoCl2 
on MDA-MB-468 cell growth. The CoCl2, at different concen-
trations, had no effect or was slightly growth inhibitory (unpub-
lished data).
CoCl2 induced changes in MDA-MB-468 cell gene ex-
pression on CAMs that were anticipated (increased uPAR and 
VEGF mRNA). CoCl2 also signifi  cantly increased tumor cell 
dissemination. Thus, we have evidence that the molecular changes 
that occur in hypoxic breast cancer cells are correlated with 
an increased propensity for these cells to disseminate in vivo. 
The increase in cancer cell dissemination may be explained by 
activation of uPAR-dependent pathways that also result in in-
creased cell migration and Matrigel invasion. However, given 
that this is a new model system, our results should be interpreted 
with caution because additional work will be necessary to evalu-
ate the effects of CoCl2 on the CAM surface, which constitutes 
the tumor cell microenvironment. Possible changes in the micro-
environment that could contribute to the increase in cancer cell 
dissemination include increased vascularization and changes in 
host cell expression of chemoattractant proteins. Additional studies 
also will be necessary to confi  rm the role of uPAR in CoCl2-
induced cancer cell dissemination on the CAMs.
In hypoxia, HIF-1α alone may regulate >70 gene products 
(Semenza, 2004); however, the spectrum of regulated genes is 
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expression in response to HIF-1α in MCF-7 cells and MDA-
MB-231 breast cancer cells, 26 genes were up-regulated in both 
cell types, whereas 63 and 117 genes were up-regulated in only 
MCF-7 or MDA-MB-231 cells, respectively (Bando et al., 2003). 
This result may be explained by multiple factors, including but 
not limited to the karyotype of the cell, gene amplifi  cation, post-
translational histone modifi  cation, CpG methylation, factors that 
affect transcript stability, and transcription regulatory factors 
present in the cell before inducing hypoxia (Costello and Plass, 
2001; Guhaniyogi and Brewer, 2001; Conley et al., 2006). Cell 
specifi  city in the response to hypoxia emerged in our studies 
when we probed various cell lines for uPAR mRNA expression 
by qPCR. Our results and prior results reported by others 
(Graham et al., 1999; Rofstad et al., 2002) indicate that increased 
uPAR expression may be observed frequently but not uniformly 
in hypoxia. Therefore, consideration of other receptors, such 
as the EpoR and c-met, which may be activated in hypoxia 
(Pennacchietti et al., 2003; Lester et al., 2005), remains important. 
Although these receptors activate overlapping signaling pathways, 
the complete activity of each receptor is unique. In ZR-75-1 and 
SCC15 cells, hypoxia induced signifi  cantly increased uPAR 
mRNA expression and cellular changes consistent with EMT. 
Thus, the correlation of uPAR expression with EMT in hypoxia 
was extended beyond the MDA-MB-468 cell system. However, 
we have not yet determined whether the increase in uPAR ex-
pression is responsible for hypoxia-induced EMT in these other 
two cell lines. Understanding how uPAR and other hypoxia-
activated receptors function as regulators of cancer cell physiol-
ogy in hypoxia remains an important goal.
Materials and methods
Antibodies and reagents
Snail-speciﬁ  c polyclonal antibody and E-cadherin–speciﬁ  c monoclonal 
antibody (HECD-1) were obtained from Abcam. uPAR-speciﬁ  c antibodies 
399R and 3932 and uPA-speciﬁ   c antibody 3471 were obtained from 
American Diagnostica, Inc. Rac1- and HIF-1α–speciﬁ   c monoclonal anti-
bodies were purchased from BD Biosciences. Rac/Cdc42 assay reagent, 
which includes residues 67–150 of p21-activated kinase fused to glutathi-
one-S-transferase and coupled to glutathione–Sepharose (PAK-1 PBD) was 
purchased from Millipore. Polyclonal antibody that recognizes total ERK/
MAPK was obtained from Millipore. Antibodies that detect phosphorylated 
ERK/MAPK, phosphorylated Akt, and phosphorylated GSK-3β were ob-
tained from Cell Signaling Technologies. Vimentin-speciﬁ  c monoclonal 
antibody, tubulin-speciﬁ  c monoclonal antibody, nonspeciﬁ  c murine IgG, 
and rabbit IgG were obtained from Sigma-Aldrich. The MEK inhibitor, 
PD098059; the PI3K inhibitor, LY294002; and Akt inhibitor were obtained 
from EMD Biosciences. Type I collagen was purchased from Southern Bio-
technology Associates, Inc. NHS-Fluorescein was obtained from Pierce 
Chemical Co. The Alexa Fluor 594 protein-labeling kit was obtained from 
Invitrogen. qPCR reagents, including primers and probes for human uPAR, 
Snail, VEGF, and HPRT-1 were obtained from Applied Biosystems. Syn-
thetic peptide α325 and its scrambled version, scα325, were obtained 
from AnaSpec.
The expression construct encoding DN-MEK1 (S217→A) in pBABE 
was previously described (Catling et al., 1995). pKH3-N17Rac1, which 
encodes DN-Rac1, was provided by I. Macara (University of Virginia, 
Charlottesville, VA). The expression construct encoding full-length human 
uPAR (pcDNA-uPAR) was previously described (Jo et al., 2003). pMAX-
GFP, which encodes GFP, was obtained from Amaxa.
Cell culture
MDA-MB-468, MDA-MB-435, ZR-75-1, SCC15, MDA-MB-231, and A431 
cells were obtained from American Type Culture Collection. SK-BR3 cells 
and low-passage MCF-7 cells were provided by S.J. Parsons (University of 
Virginia, Charlottesville, VA). SK-BR3 cells were cultured in DME (HyClone) 
supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml strep  to-
mycin. MDA-MB-231 cells were cultured in Leibowitz-15 medium (HyClone) 
with 10% FBS, penicillin, and streptomycin. MCF-7 cells were cultured in 
RPMI (HyClone) with 10% FBS, penicillin, and streptomycin. SCC15 cells 
were cultured in a 1:1 mixture of DME/Ham’s-F12 with 10% FBS. ZR-75-1 
cells were cultured in RPMI with 2 mM L-glutamine, supplemented with 18 mM 
sodium bicarbonate, 25 mM glucose, 10 mM Hepes, 1.0 mM sodium 
pyruvate, 10% FBS, penicillin, and streptomycin.
Silencing of uPAR gene expression in MDA-MB-468 breast cancer 
cells was accomplished using the pSUPER vector system (Oligoengine). The 
uPAR sequence, A  G  C  C  G  T  T  A  C  C  T  C  G  A  A  T  G  C  A  , corresponding to nucleo-
tides 397–419 of the coding region and ﬁ  tting the pattern AA(N19)TT with 
 50% GC content, was cloned into pSUPER. MDA-MB-468 cells were 
transfected with this construct or with empty vector using Lipofectamine 
2000 (Invitrogen) and selected with 1 μg/ml puromycin. uPAR gene knock-
down was assessed by qPCR.
MDA-MB-468 cells that overexpress human uPAR were prepared 
by transfecting cells with pcDNA-uPAR or with empty vector (pcDNA) using 
Lipofectamine 2000. After selection for 14 d with 500 μg/ml hygro-
mycin, single-cell clones were established and screened for uPAR expression 
by immunoblot analysis. GFP-expressing MDA-MB-468 cells were gener-
ated by transduction with the lentivirus, pCMV-GIN-Zeo (Open Biosystems), 
followed by selection with 100 μg/ml zeocin. The brightest 10% of the 
GFP-expressing cells were selected by FACS and propagated for use in in 
vivo experiments.
Immunoﬂ  uorescence microscopy
MDA-MB-468 cells were plated on sterile coverslips. After 18 h, the cells 
were washed and incubated in serum-free medium under hypoxic (1.0% 
O2) or normoxic (21% O2) conditions for 50 h. Cultures were ﬁ  xed in 4% 
formaldehyde, permeabilized with 0.2% Triton X-100, and incubated with 
antibodies speciﬁ  c for E-cadherin, vimentin, or Snail for 18 h, followed by 
secondary antibody conjugated with Alexa Fluor 488 and phalloidin con-
jugated with Alexa Fluor 568 for 1 h (Invitrogen). Control cultures were 
treated equivalently except for the omission of primary antibody. Prepara-
tions were mounted on slides using ProLong Gold with DAPI (Invitrogen) 
and examined using a ﬂ   uorescent microscope (DMIRE2; Leica). Images 
were obtained using a 63× oil-immersion objective (NA 1.4) and a 
Hamamatsu digital camera with Simple PCI software at room temperature. 
Deconvolution was performed using Simple PCI software.
Cell migration and invasion assays
Cell migration was studied using 6.5-mm Costar Transwell chambers with 
8-μm pores (Corning), as previously described (Nguyen et al., 1998). The 
Transwell membranes were precoated with 20% FBS on the underside only 
for 2 h at 37°C. Cells in suspension were treated with 25 μg/ml uPAR-
speciﬁ  c antibody 399R, 25 μg/ml uPA-speciﬁ  c antibody, 25 μg/ml non-
speciﬁ  c murine IgG, 25 μg/ml rabbit IgG, 50 μM PD098059, or with 
vehicle for 15 min before adding the cells to the top chamber (10
5 cells per 
Transwell). The bottom chamber contained 10% FBS. Cells were allowed 
to migrate in 21 or 1.0% O2. In separate studies, the indicated concentra-
tion of CoCl2 was added to both chambers. Studies were allowed to pro-
ceed for 24 h. At that time, nonmigrating cells were removed from the top 
surface of each Transwell using a cotton swab. Transwell membranes were 
then stained with Diff-Quik (Dade-Behring). Cells that migrated through the 
membrane to the lower surface were counted by light microscopy.
To study the migration of GFP-expressing cells from transiently trans-
fected preparations, translucent Biocoat Cell Culture Inserts (BD Bio-
sciences) were used instead of Transwell membranes. Cells were cotransfected 
with pMAX-GFP and with constructs encoding DN-MEK, DN-Rac1, or uPAR 
at a ratio of 1:3. Control cells were transfected with pMAX-GFP and with 
the empty vector corresponding to each construct. Transmembrane migra-
tion was allowed to occur for 24 h. Nonmigrating cells were removed with 
a cotton swab, and the membranes were ﬁ  xed in 4% formaldehyde. Cells 
expressing GFP were counted by ﬂ  uorescent microscopy.
To study cell invasion, Biocoat Inserts containing reconstituted, 
growth factor–reduced Matrigel (BD Biosciences) were purchased. Cells 
that were treated with antibodies or PD098059 and untreated cells were 
added above the Matrigel matrix. FBS was added to the lower chamber as 
described for the cell migration experiments. Matrigel invasion was al-
lowed to progress for 24 h in 21 or 1.0% O2. The Matrigel and cells on 
the top membrane surface were removed with a cotton swab. Penetration 
of cells to the underside of the membrane was determined as described for 
the cell migration experiments.UPAR INDUCES EMT IN HYPOXIC BREAST CANCER CELLS • LESTER ET AL. 435
Collagen remodeling
100 μg/ml type I collagen was adsorbed to glass coverslips by incubation 
for 24 h at 4°C and labeled with ﬂ  uorescein or Alexa Fluor 594. MDA-MB-
468 cells and subclones thereof were allowed to adhere to the coverslips 
and cultured for 24 h in 21 or 1.0% O2. The preparations were ﬁ  xed in 
4% formaldehyde, permeabilized with 0.5% Triton X-100, and mounted 
on slides using ProLong Gold with DAPI. Images were obtained using a 
ﬂ  uorescent microscope (DMIRE2; Leica) on a Hamamatsu digital camera 
and Simple PCI software.
Immunoblot analysis
MDA-MB-468 cells and subclones thereof were cultured in 60-mm dishes. 
The cells were transferred to serum-free medium for 6 h and exposed 
to 1.0% O2 or 100 μΜ CoCl2 for 15 h. Control cultures were maintained 
in 21% O2. Cell extracts were prepared in ice-cold RIPA buffer (20 mM 
sodium phosphate, 150 mM NaCl, pH 7.4, 1% NP-40, 0.1% SDS, and 0.5% 
deoxycholic acid) containing complete protease inhibitor cocktail (Roche) 
and 1 mM sodium orthovanadate. The protein concentration in each extract 
was determined by bicinchoninic acid assay (Sigma-Aldrich). Cell extracts 
were subjected to SDS-PAGE on 10% slabs. Proteins were transferred to 
polyvinylidene diﬂ  uoride membranes and probed with antibodies that de-
tect phosphorylated ERK/MAPK, human uPAR, vimentin, phosphorylated 
Akt, phosphorylated GSK-3β, and snail. The same membranes also were 
probed to detect tubulin or total ERK/MAPK as a loading control.
Analysis of Rac1 activation
Afﬁ  nity precipitation of active Rac1 was performed using the fusion protein 
PAK-1 PBD, which binds speciﬁ   cally to the active, GTP-bound forms of 
Rac1 and Cdc42 (Azim et al., 2000). MDA-MB-468 and subclones thereof 
were cultured in 10-cm plates in serum-free medium for 6 h and exposed 
to 1.0% O2 or 100 μΜ CoCl2 for 15 h. Control cultures were maintained 
in 21% O2. Cell extracts were prepared in ice-cold RIPA buffer containing 
protease inhibitor cocktail and 1 mM sodium orthovanadate. The extracts 
were incubated with 20 μg PAK-1 PBD coupled to glutathione–Sepharose 
for 60 min at 4°C. The glutathione–Sepharose was washed three times and 
treated with SDS sample buffer to dissociate the PAK-1 PBD and associated 
proteins. Cell extracts were subjected to SDS-PAGE on 12% slabs, and 
immunoblot analysis was performed to detect Rac1. Samples of each cell 
extract were also subjected to immunoblot analysis before incubation with 
PAK-1 PBD to determine total Rac1 and tubulin, as a loading control.
qPCR
Total RNA was extracted using the RNeasy kit (QIAGEN). cDNA was syn-
thesized using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Inc.). 
qPCR was performed using a System 7300 instrument (Applied Biosystems) 
and a one-step program: 95°C for 10 min, 95°C for 30 s, and 60°C for 
1 min, for 40 cycles. HPRT-1 gene expression was measured as a normalizer. 
Results were analyzed by the relative quantity (∆∆Ct) method. Experiments 
were performed in triplicate with internal duplicate determinations.
Chicken CAM assay
The original assay for studying tumor metastasis from tumors grown on 
CAMs (Kim et al., 1998) was modiﬁ  ed to facilitate analysis of breast can-
cer cells. In brief, fertilized white leghorn eggs (McIntyre Farms) were incu-
bated for 9 d before tumor cell inoculation in a rotary incubator at 38°C. 
GFP-expressing MDA-MB-468 cells were suspended at 4°C in Matrigel at 
a concentration of 4 × 10
7 cells/ml. A window was cut in the eggshell 
above the dropped CAM and a 1.0-cm
2 sterile cotton gauze with a 4-mm
2 
center cutout was placed on the membrane. 2 × 10
6 MDA-MB-468 cells 
were inoculated onto the CAM through the center of the gauze. To model 
hypoxia on the CAMs, 25 μl OptiMEM (Invitrogen) medium, with or with-
out 100 μM CoCl2, was applied to the gauze daily for 11 d. Because the 
gauze was rewet every day, and the tumor was always growing under-
neath the gauze, we assured saturation of the tumor with CoCl2. At devel-
opmental day 20, necropsy was performed on the developing chick 
embryo. The heart and lungs were isolated, and cell dissemination was 
quantiﬁ  ed under ﬂ  uorescent microscopy by counting the cells/cell clusters. 
In parallel experiments, tumors were harvested after 4 d of growth on the 
CAMs. RNA was isolated and subjected to qPCR analysis to determine lev-
els of human uPAR and VEGF mRNA.
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